argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
21 sep 2022 - 07:06
Statutory name
argenx SE
Title
argenx Submits Biologics License Application to U.S. Food and Drug Administration for Subcutaneous Efgartigimod for Treatment of Generalized Myasthenia Gravis
Date last update: 28 October 2026